Loading candles…
Gujarat Kidney and Super Speciality Limited, incorporated in 2019 and headquartered in Vadodara, Gujarat, operates in the healthcare industry. The company provides multispeciality healthcare services focusing on nephrology, urology, and other super-speciality medical services through a dedicated hospital facility. Its offerings include comprehensive kidney care, diagnostics, surgical interventions, and long-term management of renal conditions. Positioned as a specialized center for high-end medical care in these core domains, the company serves patients primarily in Gujarat, India. No information on founders, key management, subsidiaries, or stock exchange listings is disclosed.
This page is a live market overview for GUJARAT KIDNEY N SUP SP L (GKSL) on the NSE. As a listed security, GUJARAT KIDNEY N SUP SP L is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for GKSL before placing trades on tick2trade.
As of the latest feed, GKSL last traded at ₹134.38 on NSE, up ₹0.43 (0.32%) from the previous close of ₹133.95. Today's session range is ₹132.5 – ₹135.27, against a 52-week band of ₹98.36 – ₹148.34. Traded volume today stands at 1.21L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for GKSL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether GKSL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for GUJARAT KIDNEY N SUP SP L before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in GKSL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated GKSL option chain page linked from this overview.
| Unaudited Results - FY26 | To consider and approve the unaudited standalone and consolidated financial results for the period ended Jun 30, 2026 | 14 Aug 2026 |
| Audited Results - Q4 & FY26 | To consider and approve the audited financial results for the quarter and year ended March 31, 2026 and other matters | 28 May 2026 |
| Results - FY25 | The Company has informed the Exchange that a Board meeting to be held on February 13, 2026 has been re-scheduled. Further, the Company has informed the Excha… | 14 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and other business matters | 13 Feb 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.